IDB's sale of Clal Insurance to Macrolink collapses

Eduardo Elsztain

The Chinese group were deterred by the uncertainty of whether the deal would be approved by Israel's regulator.

IDB Development Corp. (TASE: IDBD), controlled by Eduardo Elsztain, has reported to the Tel Aviv Stock Exchange (TASE), that the sale of Clal Insurance Enterprises Holdings Ltd. (TASE: CLIS) to China's Macrolink Group has collapsed.

According to the report, Macrolink's representatives met with Ministry of Finance officials over the past few days, and were concerned about the uncertainty surrounding possible regulatory approval of the deal. Their concerns had been raised by 'developments and information about other deals in Israel's insurance market, which had increased the aforementioned uncertainty."

IDB Development said that at present there are no talks with any parties for the sale of Clal Insurance and that at board meeting would be convened to discuss the matter.

Following the failure of the talks, Moshe Tery, chairman of the Israel Securities Authority, who was appointed as Clal Insurance's trustee by the Ministry of Finance, will attempt to sell the company's shares in the way he sees fit included sales on the TASE.

It is believed that Macrolink agreed to pay NIS 2.4 billion for a 55% stake in Clal Insurance, a 70% premium on the company's market cap.

Published by Globes [online], Israel business news - - on January 6, 2016

© Copyright of Globes Publisher Itonut (1983) Ltd. 2016

View comments in rows
Update by email about comments talkback
Your name
Please insert your name
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Eduardo Elsztain
Eduardo Elsztain
Twitter Facebook Linkedin RSS Newsletters גלובס MAD Conference 2017